Literature DB >> 6605303

The interaction of specific T-cell help and non-specific B-cell growth factors in the production of anti-tetanus antibody by human B cells grown in serum-free microcultures.

M K Brenner, C A Newton, M E North, C Weyman, J Farrant.   

Abstract

Apart from a brief period after in-vivo immunization, only a minority of human donors provide peripheral lymphocytes that synthesize specific antibody on stimulation with tetanus toxoid in vitro. A 20 microliters hanging drop microculture technique using serum-free medium has been adapted to analyse the conditions under which B cells mature into antibody-secreting cells. Multiple permutations of antigen dose, cell concentration and T:B cell ratios have been examined. The results indicate that in-vitro failure of antigen response by the majority of donors is not due simply to an inappropriate choice of culture conditions. The addition to antigen-stimulated cultures of a lectin-free conditioned medium derived from pokeweed mitogen-stimulated peripheral lymphocytes, enables B cells from the majority of donors to produce high titres of specific antibody, in a T-dependent manner, for up to 24 months after immunization. The observed failure of prolonged antigen responsiveness in vitro thus appears to represent a failure to expand a population of antigen-specific B cells, rather than indicating an absence of such clones.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605303      PMCID: PMC1454274     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.

Authors:  R H Stevens; A Saxon
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

2.  Letter: T cell-dependent mediator in the immune response.

Authors:  H Waldmann; A Munro
Journal:  Nature       Date:  1973-06-08       Impact factor: 49.962

3.  Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures.

Authors:  O Sjöberg; J Andersson; G Möller
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

4.  Induction of antigen-specific human suppressor T lymphocytes in vitro.

Authors:  F UytdeHaag; C J Heynen; R E Ballieux
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

5.  Complete replacement of serum in primary cultures of erythropoietin-dependent red cell precursors (CFU-E) by albumin, transferrin, iron, unsaturated fatty acid, lecithin and cholesterol.

Authors:  N N Iscove; L J Guilbert; C Weyman
Journal:  Exp Cell Res       Date:  1980-03       Impact factor: 3.905

6.  Antigen-specific and nonspecific mediators of T cell/B cell cooperation. I. Evidence for their production by different T cells.

Authors:  P C Marrack; J W Kappler
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

7.  Specific in vitro antibody response to influenza virus by human blood lymphocytes.

Authors:  R E Callard
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

8.  In vitro studies on H-2-linked unresponsiveness to synthetic polypeptides. III. Production of an antigen-specific T helper cell factor to (T,G)-A--L.

Authors:  S Howie; M Feldman
Journal:  Eur J Immunol       Date:  1977-07       Impact factor: 5.532

9.  Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes.

Authors:  N N Iscove; F Melchers
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

10.  Antigen-specific helper factor in man.

Authors:  F B Mudawwar; E J Yunis; R S Geha
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  7 in total

1.  Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals.

Authors:  S S Chiou; K Yamauchi; T Nakanishi; H Obata
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

2.  Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; G Valesini; M Levrero; C Zaccari; A Van Dyke; M Falco; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

Review 3.  Antibody engineering, a strategy for the development of monoclonal antibodies.

Authors:  O T Schönherr; E H Houwink
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

4.  Non-specific factor enhancement of human in vitro antigen-dependent antibody synthesis: role of B cell activation and T cell help.

Authors:  M K Brenner; M E North; H R Chadda; J Farrant
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

5.  Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.

Authors:  M Benkerrou; D W Wara; M Elder; Y Dror; A Merino; B W Colombe; M Garovoy; M J Cowan
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

6.  Thymoma and hypogammaglobulinaemia with and without T suppressor cells.

Authors:  M K Brenner; J G Reittie; H R Chadda; A Pollock; G L Asherson
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

7.  1 alpha,25-dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: an analysis using serum-free culture conditions.

Authors:  K Shiozawa; S Shiozawa; S Shimizu; T Fujita
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.